Table 4.
N | Regression to normotension | Transition to white coat hypertension | Persistence of masked hypertension | Progression to sustained hypertension | |
---|---|---|---|---|---|
From baseline to 5 years (N = 232) | |||||
Men | 126 | 43 (34.1%) | 1 (0.8%) | 43 (34.1%) | 39 (31%) |
Women | 106 | 29 (27.4%) | 0 | 35 (33%) | 42 (39.6%) |
| |||||
Total | 232 | 72 (31.0%) | 1 (0.5%) | 78 (33.6%) | 81 (34.9%) |
| |||||
Within-subject masked hypertension persistence (N = 88)* | |||||
Men | 47 | 13 (27.7%) | 0 | 22 (46.8%) | 12 (25.5%) |
Women | 41 | 8 (19.5%) | 0 | 21 (51.2%) | 12 (29.3%) |
| |||||
Total | 88 | 21 (23.9%) | 0 | 43 (48.8%) | 24 (27.3%) |
*Hypertension categories evolution from 3 to 5 years among participants with masked hypertension both at baseline and after 3 years.